FDA approves AbbVie's psoriasis blockbuster-to-be Skyrizi - PMLiVE

FDA approves AbbVie's psoriasis blockbuster-to-be Skyrizi  PMLiVE

AbbVie has bagged US approval for Skyrizi – a treatment for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or ...



Comments

Popular posts from this blog

Epstein-Barr virus and autoimmune diseases

Chronic Lyme arthritis: A mystery solved?

Fibromyalgia — Latest Stories — Pain News Network